Pia Paffenholz

University Hospital Cologne

Papers

5

Total Citations

89

H-Index

4

About

Pia Paffenholz is a urological oncology researcher whose work centers on the surgical management of testicular seminoma, particularly retroperitoneal lymph node dissection (RPLND) as an alternative treatment strategy for metastatic disease. Her most significant contribution is the COTRIMS trial (Cologne Trial of Retroperitoneal Lymphadenectomy in Metastatic Seminoma), a prospective study investigating nerve-sparing RPLND in clinical stage IIA/B seminoma patients — a population traditionally managed with radiotherapy or chemotherapy despite their associated long-term toxicities. The trial's 2023 publication has already accumulated 57 citations, reflecting its immediate impact on the field and its potential to reshape treatment guidelines. Paffenholz has presented interim analyses and collaborative data alongside the Swedish Norwegian Testicular Cancer Group (SWENOTECA), strengthening the evidence base for primary surgical approaches in stage IIA–IIC disease. Her more recent work extending into post-chemotherapy RPLND across major referral centers demonstrates a broadening research scope. Through rigorous prospective trial design and international collaboration, Paffenholz is establishing surgical intervention as a viable, potentially less toxic alternative for seminoma patients, positioning her as an emerging voice in testicular cancer management.

Research Focus

Key Achievements

4
H-Index
5
Papers
89
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Retroperitoneal Lymph Node Dissection in Clinical Stage IIA/B Metastatic Seminoma: Results of the COlogne Trial of Retroperitoneal Lymphadenectomy In Metastatic Seminoma (COTRIMS)
57 citations · 2023
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: University Hospital Cologne

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago